Supriya Lifesci. (SUPRIYA)
STALWARTFairStock Score: 29/100 — RISKY
Score breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹663.1 |
| Market Cap | ₹5,271.62 Cr |
| P/E Ratio | 28.4 |
| ROCE | 27.46% |
| ROE | 20.45% |
| Dividend Yield | 0.15% |
| Profit Growth | 6.93% |
| Debt/Equity | 0 |
| Sales Growth | 11.2% |
| Promoter Holding | 68.3% |
| 52-Week Range | ₹545.5 — ₹1,085.5 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹111.47 |
Supriya Lifesci. trades with a P/E ratio of 28.4, ROCE of 27.46%, ROE of 20.45%, profit growth of 6.93%, debt-to-equity of 0. The FairStock Score of 29/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer